RGC
NASDAQ · Pharmaceuticals
Regencell Bioscience Holding
$5.41
-0.05 (-0.92%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-80.48%
1Y
-61.27%
YTD
-73.66%
Open$5.48
Previous Close$5.46
Day High$5.75
Day Low$5.24
52W High$69.00
52W Low$4.51
Volume—
Avg Volume206.7K
Market Cap2.68B
P/E Ratio—
EPS$-0.01
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$27.08
Below
SMA 200
$18.57
Below
RSI (14)
63.8
Neutral
Trend
Golden Cross
Bullish
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.66B | 3.76B | 3.59B |
| Net Income | 706.46M | 788.49M | 815.65M |
| Profit Margin | 19.3% | 21.0% | 22.7% |
| EBITDA | 1.06B | 1.04B | 1.04B |
| Free Cash Flow | 809.03M | 638.27M | 648.55M |
| Rev Growth | +1.6% | +15.1% | +20.8% |
| Debt/Equity | 0.23 | 0.28 | 0.31 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |